Results 101 to 110 of about 31,699 (207)

FIC values of Ampicillin/sulbactam plus amikacin combination.

, 2017
FIC values of Ampicillin/sulbactam plus amikacin combination.
Mona M. Abdelkader (3753058), Mohammad M. Aboulwafa (3753052), Marwa A. El-Ashry (3753055), Khaled M. Aboshanab (3753061)   +3 more
core   +1 more source

Microbiological assay of ampicillin in serum and aqueous humor of patients given ampicillin-sulbactam injection

Indian Journal of Ophthalmology, 1998
The aim of this study was to determine the bacterial growth inhibitory activities of ampicillin in aqueous humor and serum of patients administered ampicillin-sulbactam combination intramuscularly prior to cataract surgery.
Madhavan Hajib, Biswas Amitava, Malathy Jatnbulingam, Mukesh Bickol   +3 more
doaj  

Antibacterial activity of enmetazobactam against Acinetobacter spp.: a molecular dissection of mechanism of action and resistance determinants

Antimicrobial Agents and Chemotherapy
The persistence of multidrug-resistant Acinetobacter baumannii remains a clinical challenge. Cefepime/enmetazobactam is a novel combination with demonstrated activity against extended-spectrum β-lactamase-producing Enterobacterales, but its activity ...
Gabriela-Alejandra Báez-Barroso, Arianna Rodríguez-Coello, Juan Carlos Vázquez-Ucha, Silvia López-Argüello, Michelle Outeda-García, Lucía González-Pinto, Andrea García-Pose, Paula Guijarro-Sánchez, Isaac Alonso-García, Emilio Lence, Concepción González-Bello, Antonio Oliver, Jorge Arca-Suárez, Bartolome Moya, Germán Bou, Alejandro Beceiro   +15 more
doaj   +1 more source

Sulbactam for carbapenem-resistant Acinetobacter baumannii infections: a literature review

Carbapenem-resistant Acinetobacter baumannii (CRAB) is characterized as a critical priority pathogen with restricted therapeutic options. To date, the most effective antimicrobial treatment against this difficult-to-treat bacterial strain has not been ...
Agouridis, Aris P, Alon-Ellenbogen, Danny, Mazonakis, Nikolaos, Ishak, Angela, Spernovasilis, Nikolaos, Tsioutis, Constantinos   +5 more
core   +1 more source

Chinese expert consensus on the use of sulbactam to treat patients infected with Acinetobacter baumannii in the neurosurgical intensive care unit

Chinese Journal of Contemporary Neurology and Neurosurgery
Treatment of neurosurgical intensive care patients infected with multidrug resistant (MDR) or extensive drug resistant (XDR) Acinetobacter baumannii presents significant challenges and is associated with high mortality rates.
Neurosurgical Branch, Chinese Medical Association, Chinese Neurosurgical Intensive Care Management Collaborative Group   +1 more
doaj   +1 more source

Evaluación de la asociación Amoxicilina/Sulbactam frente a Amoxicilina/Sulbactam más Gentamicina en niños con peritonitis de origen apendicular

, 2001
La apendicitis complicada y no complicada siguen teniendo una alta incidencia en la población pediátrica. La morbilidad en este grupo de pacientes está dada principalmente por sus complicaciones infecciosas, entre las cuales destacan por su frecuencia ...
Cardozo, Miriam, Matsumura, Kichiro, Basualdo, Wilma, González-Cabello, Mercedes, Escauriza, Juan José, Nicolicchia, Maria Dorotea, Martínez, Raúl, Navarro, Doris, Diaz-Escobar, María Ligia   +8 more
core  

Cefotaxime/Sulbactam: an Important Addition to the Arsenal of Inhibitor-Protected Beta-Lactam Antibiotics

Антибиотики и Химиотерапия, 2020
A new inhibitor-protected beta-lactam antibiotic has been registered in Russia, a fixed combination of antistreptococcal cephalosporin III, cefotaxime and inhibitor of beta-lactamase sulbactam in a 2:1 ratio.
S. V. Yakovlev, M. P. Suvorova
doaj  

SAM: Ampicillin/Sulbactam 8 μg/ml and 8μg/ml.

, 2015
SAM: Ampicillin/Sulbactam 8 μg/ml and 8μg/ml.
Kristina Crona (567679), Bernd Sturmfels (73407), Portia M. Mira (735579), Miriam Barlow (197488), Juan C. Meza (735580), Devin Greene (567678)   +5 more
core   +1 more source

Sulbactam [PDF]

, 2020
openaire   +1 more source

Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii

, 2014
Acinetobacter baumannii is a frequently isolated etiologic agent of nosocomial infections, especially in intensive care units. With the increase in multi-drug resistance of A.
Gunay Ertem, Fatih Temocin, Meryem Demirelli, Sami Kinikli, Fatma Sebnem Erdinc, Necla Tulek, Eda Koksal   +6 more
core